User:Mr. Ibrahem/Ertugliflozin

Ertugliflozin, sold under the brand name Steglatro, is a medication used to treat type 2 diabetes. It is used together with diet and exercise. It is taken by mouth. It should not be used in people with type 1 diabetes.

Common side effects include fungal infections of the vagina and other infections of the female reproductive system. Other side effects may include diabetic ketoacidosis (DKA), limb amputation, and Fournier's gangrene. Use in pregnancy is not recommended. It is a sodium glucose cotransporter 2 (SGLT2) inhibitor which increases the amount of glucose lost in the urine.

Ertugliflozin was approved for medical use in the United States in 2017 and Europe in 2018. In the United Kingdom 4 weeks of medication costs the NHS about £30 as of 2021. This amount in the United States is 280 USD.